Table 2.
Factors driving the preference for track 2 among Italian HCPs
| Factors | Pulmonologist (%) | Allergist (%) | GP (%) |
|---|---|---|---|
| Failure of track 1 | 34.1 | 31.9 | 38.0 |
| Use of medication in a single administration | 28.2* | 39.8*/** | 14.5 |
| Patients with mild symptoms | 20.8* | 21.2* | 13.3 |
| Higher compliance | 20.5 | 24.8* | 15.5 |
| Patients with severe symptoms | 13.4 | 12.4 | 24.7**/*** |
| Greater efficacy in exacerbation control | 13.4 | 11.5 | 23.6**/*** |
| Greater symptom efficacy | 13.1 | 11.5 | 20.4**/*** |
| Greater anti-inflammatory action | 12.5 | 13.3 | 18.0** |
| Recommended by guidelines | 12.2 | 13.3 | 17.1** |
| Greater efficacy in airway impairment | 9.8 | 8.0 | 15.5** |
*Statistically significant compared with GPs (p < 0.05)
**Statistically significant compared with pulmonologists (p < 0.05)
***Statistically significant compared with allergists (p < 0.05)